Bringing doctors together

or

A free, private network for verified physicians

Leading voices

Dr. Rebecca Shatsky

Breast Oncology · UCSD

View

Dr. Robert Bast

Breast Oncology · MD Anderson Cancer Center

View

Dr. Sara Tolaney

Breast Oncology · Dana-Farber Cancer Institute

View

Dr. Jason Mouabbi

Breast Oncology · MD Anderson Cancer Center

View

Dr. Matthew Kurian

Breast Oncology · St Elizabeth Healthcare

View

Dr. Sarah Premji

Breast Oncology

View

Dr. Roberto Leon-Ferre

Breast Oncology · Mayo Clinic College of Medicine

View

Dr. Nerea Lopetegui-Lia

Breast Oncology · OSUMC

View

Dr. Allison Kurian

Breast Oncology · SU

View

Dr. Minhtri Nguyen

Breast Oncology · Advisor

View
  • Discover your community

  • Stay current

  • A profile that represents you

  • Find your people

About RoonPrivacyTerms
    VKDr. Virginia Kaklamani

    Dr. Virginia Kaklamani

    Medical Oncology · Breast Oncology
    The University of Texas at San Antonio Health Science Center
    virginiak

    Research

    Real-World Outcomes of Elacestrant in ER+, HER2-, ESR1-Mutant Metastatic Breast Cancer

    2026

    Via Clinical Cancer Research

    Research

    Goserelin 3-Month Depot Shows Non-Inferiority to the Monthly Formulation in U.S. Patients with Premenopausal Breast Cancer: A Real-World Evidence Study

    2025

    Via Breast Cancer Research and Treatment

    Research

    Pilot Phase II Study of the Combination of Lenvatinib (L) and Eribulin (E) in Advanced Solid Tumors

    2025

    Via International Journal of Cancer

    Research

    Treatment Patterns of Goserelin 3.6 mg Once Every 4 Weeks and 10.8 mg Once Every 12 Weeks in Women With Breast Cancer: A Real-World Analysis of Patients in the United States

    2025

    Via JCO Oncology Practice

    Research

    Sequencing Therapies: Optimal Treatment for HR+/HER2- Metastatic Breast Cancer

    2024

    Via Clinical Advances in Hematology & Oncology

    Research

    Selection of Appropriate Biomarkers to Monitor Effectiveness of Ovarian Function Suppression in Pre-Menopausal Patients with ER+ Breast Cancer

    2024

    Via NPJ Breast Cancer

    Research

    Integrated Multiomic Profiling of Breast Cancer in the Chinese Population Reveals Patient Stratification and Therapeutic Vulnerabilities

    2024

    Via Nature Cancer

    Research

    Clinical and Genomic Risk for Late Breast Cancer Recurrence and Survival

    2024

    Via NEJM Evidence

    Research

    Phase III Randomized, Placebo-Controlled Trial of Endocrine Therapy ± 1 Year of Everolimus in Patients With High-Risk, Hormone Receptor-Positive, Early-Stage Breast Cancer

    2024

    Via Journal of Clinical Oncology

    Research

    Sacituzumab Govitecan in Patients with Breast Cancer Brain Metastases and Recurrent Glioblastoma: A Phase 0 Window-of-Opportunity Trial

    2024

    Via Nature Communications

    Research

    Elacestrant in ER+, HER2- Metastatic Breast Cancer with ESR1-Mutated Tumors: Subgroup Analyses from the Phase III EMERALD Trial by Prior Duration of Endocrine Therapy plus CDK4/6 Inhibitor and in Clinical Subgroups

    2024

    Via Clinical Cancer Research

    Research

    Breast Cancer: The Good, the Bad, and an Important Call to Effective Risk Reduction Strategies

    2024

    Via CA: A Cancer Journal for Clinicians

    Research

    Advances in Medical Treatment of Breast Cancer in 2022

    2023

    Via Cancer Innovation

    Research

    Clinical Characteristics, Racial Inequities, and Outcomes in Patients with Breast Cancer and COVID-19: A COVID-19 and Cancer Consortium (CCC19) Cohort Study (preprint)

    2023

    Via medRxiv

    Research

    Updates on the Preoperative Immunotherapy for Triple-Negative Breast Cancer

    2023

    Via Translational Breast Cancer Research